Kineta News

Kineta | EFFECT: Others

Nov 15, 2023 13:15

Kineta | 424B3: Prospectus

Nov 14, 2023 06:28

Kineta | 424B5: Prospectus

Oct 5, 2023 22:47

Kineta | EFFECT: Others

Jun 13, 2023 12:15

Kineta | 424B3: Prospectus

Jun 13, 2023 05:01

Kineta | 424B5: Prospectus

Apr 22, 2023 05:14

Kineta | 424B5: Prospectus

Apr 20, 2023 20:09

Kineta | EFFECT: Others

Feb 14, 2023 13:15

Kineta | 424B5: Prospectus

Feb 11, 2023 05:48

Kineta | EFFECT: Others

Jan 31, 2023 13:15

Kineta | 424B4: Prospectus

Jan 31, 2023 06:02

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 7, 2022 05:04

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 5, 2022 22:28

Yumanity Therapeutics | 424B3: Prospectus

Dec 5, 2022 22:22

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 2, 2022 05:04

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 30, 2022 05:03

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 29, 2022 05:03

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 16, 2022 05:03

Yumanity Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 14, 2022 21:50

Yumanity Therapeutics | EFFECT: Others

Nov 14, 2022 13:15